ACORDA THERAPEUTICS INC 4
4 · ACORDA THERAPEUTICS INC · Filed Oct 21, 2015
Insider Transaction Report
Form 4
Blight Andrew
Chief Scientifc Officer
Transactions
- Sale
Common Stock
2015-10-19$30.82/sh−28,800$887,501→ 75,359 total - Exercise/Conversion
Employee Stock Option (right to buy)
2015-10-19−32,500→ 0 totalExercise: $5.85Exp: 2016-03-17→ Common Stock (32,500 underlying) - Sale
Common Stock
2015-10-19$31.25/sh−3,700$115,616→ 71,659 total - Exercise/Conversion
Common Stock
2015-10-19$5.85/sh+32,500$190,125→ 104,159 total
Footnotes (4)
- [F1]Exercises and sales pursuant to a 10b5-1 Plan. The exercised options were scheduled to expire in 2016 on the expiration date reported within Table II unless exercised.
- [F2]The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $30.2200 to $31.2000 per share. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- [F3]The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $31.2006 to $31.3900 per share. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- [F4]The shares subject to these options vested in installments and were fully vested on 2/10/2010.